United States

Sarepta Therapeutics Inc (SRPT.O)

SRPT.O on Nasdaq

23 Aug 2019
Change (% chg)

$-1.46 (-1.54%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

M. Kathleen Behrens

66 2015 Independent Chairwoman of the Board

Douglas Ingram

56 2017 President, Chief Executive Officer, Director

Sandesh Mahatme

54 2017 Executive Vice President, Chief Financial Officer and Chief Business Officer

David Howton

47 2019 Executive Vice President, General Counsel, Secretary

Alexander Cumbo

48 2019 Executive Vice President and Chief Commercial Officer